1 Bourre, J.M. Dietary omega-3 Fatty acids and psychiatry: mood, behaviour, stress, depression, dementia and aging. J. Nutr. Health Aging 9, 31–38 (2005).

2 Rapoport, S.I., Rao, J.S. & Igarashi, M. Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver. Prostaglandins Leukot. Essent. Fatty Acids 77, 251–261 (2007).

3 Lauritzen, L., Hansen, H.S., Jorgensen, M.H. & Michaelsen, K.F. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog. Lipid Res. 40, 1–94 (2001).

4 Simopoulos, A.P. Evolutionary aspects of the dietary omega-6:omega-3 fatty acid ratio: medical implications. World Rev. Nutr. Diet. 100, 1–21 (2009).

5 Parker, G. et al. Omega-3 fatty acids and mood disorders. Am. J. Psychiatry 163, 969–978 (2006).

6 Mingam, R. et al. Uncoupling of interleukin-6 from its signaling pathway by dietary n-3-polyunsaturated fatty acid deprivation alters sickness behaviour in mice. Eur. J. Neurosci. 28, 1877–1886 (2008).

7 Chalon, S. Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot. Essent. Fatty Acids 75, 259–269 (2006).

8 Mackie, K. Signaling via CNS cannabinoid receptors. Mol. Cell. Endocrinol. 286, S60–S65 (2008).

9 Heifets, B.D. & Castillo, P.E. Endocannabinoid signaling and long-term synaptic plasticity. Annu. Rev. Physiol. 71, 283–306 (2009).

10 Leweke, F.M. & Koethe, D. Cannabis and psychiatric disorders: it is not only addiction. Addict. Biol. 13, 264–275 (2008).

11 Lutz, B. Endocannabinoid signals in the control of emotion. Curr. Opin. Pharmacol. 9, 46–52 (2009).

12 Hill, M.N. et al. The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants. Trends Pharmacol. Sci. 30, 484–493 (2009).

13 Krishnan, V. & Nestler, E.J. The molecular neurobiology of depression. Nature 455, 894–902 (2008).

14 Nestler, E.J. & Carlezon, W.A. Jr. The mesolimbic dopamine reward circuit in depression. Biol. Psychiatry 59, 1151–1159 (2006).

15 Lafourcade, M. et al. Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex. PLoS ONE 2, e709 (2007).

16 Robbe, D., Kopf, M., Remaury, A., Bockaert, J. & Manzoni, O.J. Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc. Natl. Acad. Sci. USA 99, 8384–8388 (2002).

17 Kauer, J.A. & Malenka, R.C. LTP: AMPA receptors trading places. Nat. Neurosci. 9, 593–594 (2006).

18 Hayton, S.J. Lovett-Barron, M., Dumont, E.C. & Olmstead, M.C. Target-specific encoding of response inhibition: increased contribution of AMPA to NMDA receptors at excitatory synapses in the prefrontal cortex. J. Neurosci. 30, 11493–11500 (2010).

19 Robbe, D., Alonso, G., Chaumont, S., Bockaert, J. & Manzoni, O.J. Role of p/q-Ca2+ channels in metabotropic glutamate receptor 2/3-dependent presynaptic long-term depression at nucleus accumbens synapses. J. Neurosci. 22, 4346–4356 (2002).

20 Mato, S., Lafourcade, M., Robbe, D., Bakiri, Y. & Manzoni, O.J. Role of the cyclic-AMP/PKA cascade and of P/Q-type Ca. channels in endocannabinoid-mediated long-term depression in the nucleus accumbens. Neuropharmacology 54, 87–94 (2008).

21 Mato, S. et al. A single in vivo exposure to delta 9THC blocks endocannabinoid-mediated synaptic plasticity. Nat. Neurosci. 7, 585–586 (2004).

22 Mikasova, L., Groc, L., Choquet, D. & Manzoni, O.J. Altered surface trafficking of presynaptic cannabinoid type 1 receptor in and out synaptic terminals parallels receptor desensitization. Proc. Natl. Acad. Sci. USA 105, 18596–18601 (2008).

23 Mato, S., Robbe, D., Puente, N., Grandes, P. & Manzoni, O.J. Presynaptic homeostatic plasticity rescues long-term depression after chronic Delta 9-tetrahydrocannabinol exposure. J. Neurosci. 25, 11619–11627 (2005).

24 Martin, B.R. Sim-Selley, L.J. & Selley, D.E. Signaling pathways involved in the development of cannabinoid tolerance. Trends Pharmacol. Sci. 25, 325–330 (2004).

25 Schlosburg, J.E., Sim-Selley, L.J., Liu, Q.S., Lichtman, A.H. & Cravatt, B.F. Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat. Neurosci. 13, 1113–1119 (2010).

26 Berger, A. et al. Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets. Proc. Natl. Acad. Sci. USA 98, 6402–6406 (2001).

27 Matias, I. et al. Effect of polyunsaturated fatty acids on endocannabinoid and N-acyl-ethanolamine levels in mouse adipocytes. Biochim. Biophys. Acta 1781, 52–60 (2008).

28 Watanabe, S., Doshi, M. & Hamazaki, T. n-3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice. Prostaglandins Leukot. Essent. Fatty Acids 69, 51–59 (2003).

29 Vinod, K.Y. & Hungund, B.L. Role of the endocannabinoid system in depression and suicide. Trends Pharmacol. Sci. 27, 539–545 (2006).

30 DeMar, J.C. Jr. et al. One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats. J. Lipid Res. 47, 172–180 (2006).

31 Porsolt, R.D., Brossard, G., Hautbois, C. & Roux, S. Rodent models of depression: forced swimming and tail suspension behavioral despair tests in rats and mice. Curr. Protoc. Neurosci. 14, 8.10A.1–8.10A.10 (2001).

32 Haller, J., Varga, B., Ledent, C., Barna, I. & Freund, T.F. Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice. Eur. J. Neurosci. 19, 1906–1912 (2004).

33 Urigüen, L. Perez-Rial, S., Ledent, C., Palomo, T. & Manzanares, J. Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors. Neuropharmacology 46, 966–973 (2004).

34 Simon, P., Dupuis, R. & Costentin, J. Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav. Brain Res. 61, 59–64 (1994).

35 Bambico, F.R., Katz, N., Debonnel, G. & Gobbi, G. Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. J. Neurosci. 27, 11700–11711 (2007).

36 Evans, D.L. et al. Mood disorders in the medically ill: scientific review and recommendations. Biol. Psychiatry 58, 175–189 (2005).

37 Samat, A., Tomlinson, B., Taheri, S. & Thomas, G.N. Rimonabant for the treatment of obesity. Recent Patents Cardiovasc. Drug Discov. 3, 187–193 (2008).

38 Jacob, W. et al. Endocannabinoids render exploratory behaviour largely independent of the test aversiveness: role of glutamatergic transmission. Genes Brain Behav. 8, 685–698 (2009).

39 Steiner, M.A. et al. Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice. Pharmacogenomics J. 8, 196–208 (2008).

40 Steiner, M.A., Marsicano, G., Wotjak, C.T. & Lutz, B. Conditional cannabinoid receptor type 1 mutants reveal neuron subpopulation-specific effects on behavioral and neuroendocrine stress responses. Psychoneuroendocrinology 33, 1165–1170 (2008).

41 Liperoti, R., Landi, F., Fusco, O., Bernabei, R. & Onder, G. Omega-3 polyunsaturated fatty acids and depression: a review of the evidence. Curr. Pharm. Des. 15, 4165–4172 (2009).

42 Folch, J., Lees, M. & Sloane Stanley, G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497–509 (1957).

43 Morrison, W.R. & Smith, L.M. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J. Lipid Res. 5, 600–608 (1964).

44 Kasanetz, F. & Manzoni, O.J. Maturation of excitatory synaptic transmission of the rat nucleus accumbens from juvenile to adult. J. Neurophysiol. 101, 2516–2527 (2009).

45 Di Marzo, V. et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410, 822–825 (2001).

46 De Marchi, N. et al. Endocannabinoid signalling in the blood of patients with schizophrenia. Lipids Health Dis. 2, 5 (2003).

47 Matias, I. et al. Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. J. Clin. Endocrinol. Metab. 91, 3171–3180 (2006).

48 Richardson, D., Ortori, C.A., Chapman, V., Kendall, D.A. & Barrett, D.A. Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry. Anal. Biochem. 360, 216–226 (2007).

49 Kingsley, P.J. & Marnett, L.J. LC-MS-MS analysis of neutral eicosanoids. Methods Enzymol. 433, 91–112 (2007).